1-1 of 1
Philip Hall, Pharm.D.
Close
Save search
Sort by
Journal Articles

The Use of DT388-IL3 Fusion Protein in Patients with Refractory Acute Myeloid Leukemia(AML).

Free
Debashish Misra, M.D., Arthur Frankel, M.D., Philip Hall, Pharm.D., Tie Fu Liu, M.D., Jennifer Black, R.N., Joseph O. Moore, M.D., Carlos de Castro, M.D., Jon P. Gockerman, M.D., Cristina Gasparetto, M.D., Mitchell Horwitz, M.D., Patricia H. Davis, R.N., Nelson J. Chao, M.D., David A. Rizzieri, M.D.
Journal: Blood
Blood (2004) 104 (11): 4513.
https://doi.org/10.1182/blood.V104.11.4513.4513
Published: 2004